Connecticut Attorney General Demands Drug Makers Abandon Unlawful 340B Actions

Connecticut Attorney General William Tong sent letters to Eli Lilly, Astra Zeneca, Merck, Sanofi and Novartis demanding the drug makers immediately abandon unlawful actions imperiling access to affordable prescriptions for low-income patients under the 340B program. Attorney General Tong states that the drug makers actions directly undermine the 340B Drug Pricing Program, obstruct patient access to critical prescription medications, and devastate the financial stability of healthcare centers and hospitals serving vulnerable communities. PACHC is meeting with the Pennsylvania Office of Attorney General to discuss potential action by their office. Click here to download the letters.